Laurel Wealth Advisors Inc. Increases Stake in Lockheed Martin Co. (NYSE:LMT)

Share on StockTwits

Laurel Wealth Advisors Inc. increased its position in shares of Lockheed Martin Co. (NYSE:LMT) by 24.4% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 3,831 shares of the aerospace company’s stock after buying an additional 751 shares during the period. Laurel Wealth Advisors Inc.’s holdings in Lockheed Martin were worth $1,393,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. Advisors Preferred LLC acquired a new position in shares of Lockheed Martin in the first quarter worth about $26,000. Krane Funds Advisors LLC acquired a new stake in Lockheed Martin in the second quarter worth approximately $26,000. Heritage Wealth Advisors lifted its position in Lockheed Martin by 304.3% in the first quarter. Heritage Wealth Advisors now owns 93 shares of the aerospace company’s stock worth $28,000 after purchasing an additional 70 shares during the period. Paragon Capital Management LLC lifted its position in Lockheed Martin by 406.7% in the second quarter. Paragon Capital Management LLC now owns 76 shares of the aerospace company’s stock worth $28,000 after purchasing an additional 61 shares during the period. Finally, MRA Associates USA LLC acquired a new stake in shares of Lockheed Martin during the 2nd quarter valued at $38,000. Hedge funds and other institutional investors own 78.94% of the company’s stock.

In related news, SVP Maryanne Lavan sold 1,003 shares of the business’s stock in a transaction that occurred on Wednesday, July 24th. The stock was sold at an average price of $365.50, for a total transaction of $366,596.50. Following the completion of the sale, the senior vice president now directly owns 1,478 shares in the company, valued at $540,209. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director James D. Taiclet, Jr. purchased 1,354 shares of the company’s stock in a transaction that occurred on Friday, August 9th. The shares were purchased at an average price of $376.32 per share, with a total value of $509,537.28. Following the completion of the transaction, the director now directly owns 1,354 shares of the company’s stock, valued at approximately $509,537.28. The disclosure for this purchase can be found here. Insiders sold 22,503 shares of company stock valued at $8,292,527 over the last three months. 0.35% of the stock is currently owned by corporate insiders.

A number of analysts have recently issued reports on the company. Credit Suisse Group increased their target price on Lockheed Martin from $369.00 to $379.00 and gave the company a “neutral” rating in a report on Wednesday, July 24th. DZ Bank reaffirmed a “hold” rating on shares of Lockheed Martin in a research note on Thursday, July 25th. JPMorgan Chase & Co. lifted their target price on shares of Lockheed Martin from $360.00 to $395.00 and gave the company a “neutral” rating in a research report on Wednesday, July 24th. Barclays lifted their target price on shares of Lockheed Martin from $340.00 to $370.00 and gave the company an “equal weight” rating in a research report on Thursday, May 16th. Finally, UBS Group boosted their price objective on shares of Lockheed Martin from $385.00 to $420.00 and gave the stock a “buy” rating in a report on Wednesday, July 10th. Seven equities research analysts have rated the stock with a hold rating, nine have issued a buy rating and one has given a strong buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average target price of $367.86.

Shares of Lockheed Martin stock traded down $0.26 during trading on Friday, hitting $386.37. 9,630 shares of the stock traded hands, compared to its average volume of 893,514. The stock’s fifty day simple moving average is $376.12 and its 200 day simple moving average is $342.35. Lockheed Martin Co. has a 52-week low of $241.18 and a 52-week high of $393.43. The company has a current ratio of 1.20, a quick ratio of 0.96 and a debt-to-equity ratio of 4.36. The firm has a market cap of $107.68 billion, a P/E ratio of 21.63, a price-to-earnings-growth ratio of 2.53 and a beta of 0.95.

Lockheed Martin (NYSE:LMT) last issued its quarterly earnings results on Tuesday, July 23rd. The aerospace company reported $5.00 earnings per share for the quarter, topping the Zacks’ consensus estimate of $4.74 by $0.26. Lockheed Martin had a return on equity of 297.37% and a net margin of 10.18%. The business had revenue of $14.42 billion for the quarter, compared to analyst estimates of $14.17 billion. During the same quarter in the previous year, the firm earned $4.31 earnings per share. The company’s revenue was up 7.7% on a year-over-year basis. As a group, equities analysts expect that Lockheed Martin Co. will post 21.2 EPS for the current year.

The business also recently declared a quarterly dividend, which will be paid on Friday, September 27th. Shareholders of record on Tuesday, September 3rd will be issued a $2.20 dividend. This represents a $8.80 dividend on an annualized basis and a yield of 2.28%. The ex-dividend date of this dividend is Friday, August 30th. Lockheed Martin’s payout ratio is presently 49.30%.

Lockheed Martin Company Profile

Lockheed Martin Corporation, a security and aerospace company, engages in the research, design, development, manufacture, integration, and sustainment of technology systems, products, and services worldwide. It operates through four segments: Aeronautics, Missiles and Fire Control (MFC), Rotary and Mission Systems (RMS), and Space.

Featured Article: Trading Ex-Dividend Strategy

Institutional Ownership by Quarter for Lockheed Martin (NYSE:LMT)

Receive News & Ratings for Lockheed Martin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lockheed Martin and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Eversept Partners LP Has $15.71 Million Stake in Ascendis Pharma A/S
Eversept Partners LP Has $15.71 Million Stake in Ascendis Pharma A/S
Amarin Co. plc  Stock Holdings Lessened by Eversept Partners LP
Amarin Co. plc Stock Holdings Lessened by Eversept Partners LP
Eversept Partners LP Cuts Stock Holdings in Sanofi SA
Eversept Partners LP Cuts Stock Holdings in Sanofi SA
Eversept Partners LP Makes New $6.32 Million Investment in Alnylam Pharmaceuticals, Inc.
Eversept Partners LP Makes New $6.32 Million Investment in Alnylam Pharmaceuticals, Inc.
Eversept Partners LP Buys 8,930 Shares of argenx SE –
Eversept Partners LP Buys 8,930 Shares of argenx SE –
Eversept Partners LP Has $20.76 Million Holdings in Danaher Co.
Eversept Partners LP Has $20.76 Million Holdings in Danaher Co.


© 2006-2019 Ticker Report